| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $33.2M | +76.4% |
| R&D Expense | $124.4M | +14.7% |
| SG&A Expense | $43.1M | +7.1% |
| Operating Income | -$134.4M | -3.4% |
| Interest Expense | $4.7M | +123.8% |
| Net Income | -$134.5M | -2.1% |
| EPS (Basic) | -$2.26 | +37.0% |
| EPS (Diluted) | -$2.26 | +37.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $103.3M | -51.5% |
| Short-term Investments | $212.1M | +428.1% |
| Current Assets | $328.0M | +23.6% |
| Total Assets | $358.2M | +17.6% |
| Current Liabilities | $36.4M | -43.4% |
| Long-term Debt | $51.0M | -1.9% |
| Total Liabilities | $97.9M | -26.0% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$132.7M | -4.7% |
| Capital Expenditures | $1.1M | -79.7% |
| Investing Cash Flow | -$171.7M | -227.8% |
| Financing Cash Flow | $194.8M | +333.4% |
| Free Cash Flow | -$133.8M | -1.3% |
| Stockholders' Equity |
| $260.2M |
| +51.2% |